Argutus Medical
Leaders in Specialised Assay Development
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed Argutus Medical Information
Argutus Medical was acquired by
EKF Diagnostics.
The acquisition happend on 2010-12-08.
Details of the transaction were not public
Acquirer
Geographic Data
Address:
City: Dublin
State: Dublin
Zip:
Country: Ireland
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Argutus Medical is a world leader in developing and manufacturing specialised organ injury assays. Argutus Medical primarily focuses on developing ELISA tests and lateral flow rapid test devices for detection of acute kidney injury (Nephrotoxicity) and acute liver injury (Hepatotoxicity). Argutus also manufactures a range of other assays including OxyDNA, a unique test for oxidative DNA damage (Genotoxicity). Argutus Medical was previously part of Biotrin International before branching out in 2008. In 2010 Argutus Medical was acquired by EKF Diagnostics Holdings plc, a rapidly growing global health care company. Being part of EKF Diagnostics has allowed Argutus Medical to continue to focus on biomarker discovery and development of novel biomarker assays from their facility in Dublin, Ireland.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
